Natera, Inc. and Flatiron Health announced the integration of Natera's oncology testing portfolio into OncoEMR®?, Flatiron's cloud-based Electronic Medical Record (EMR) platform. The integration enables seamless electronic ordering and results delivery for Natera's onCology tests directly within the clinical workflow of thousands of U.S. cancer care providers. The two-way integration provides oncologists with a unified ordering experience for Signatera and all of Natera' oncology offerings, built directly into the EMR system.
Once processed, test results are returned electronically to the ordering provider within the OncoEMR interface, ensuring timely access to actionable insights. This creates a seamless experience for over 4,500 providers and 1,000 community-based care locations nationwide, making it even easier to incorporate molecular residual disease (MRD) testing and monitoring into routine care.
